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result in improved outcome. The aim of this study was to compare between two methods of goal
directed ﬂuid optimization using protocols guided by corrected ﬂow time (FTc) of the transesoph-
ageal doppler versus Pleth variability index (PVI group) in cirrhotic patients undergoing major
abdominal surgeries.
Methods: Sixty cirrhotic patients Child A to B scheduled for major abdominal surgery were ran-
domized into two groups. In both groups 500 mL of Ringer’s acetate was infused during induction
followed by a 2 mL/kg/h continuous infusion. In FTc group (n= 30) patients with (FTc) less than
350 ms were treated with bolus of ﬂuid challenge according to a preset protocol. In PVI group
(n= 30), PVI higher than 13% patients were given 250 mL of ﬂuid bolus.
Results: There was no signiﬁcant differences in the volume of crystalloids or colloids transfused to
both groups with a mean value of 2670 ± 1680 mL and 670 ± 330 mL in the FTc guided ﬂuid
group while mean values were 2730 ± 1760 mL and 690 ± 290 mL in the PVI ﬂuid guided group
respectively (P> 0.05). Also, there was no signiﬁcant differences between groups regarding the
intra or postoperative hemodynamic parameters. There was no signiﬁcant difference regarding
the overall morbidity or the hospital stay between the two groups (P> 0.05).Kanat El Suis-Av, El Shatby,
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Figure 1 Transesophageal Doppler
suggests hypovolaemia.
24 M.H. Abdullah et al.Conclusions: In conclusion, in cirrhotic patients Child A to B, FTc and PVI were considered to be
adequate methods for perioperative ﬂuid optimization, However, combination of every clinical ﬁnd-
ing, recent and conventional monitoring techniques to all haemodynamic data should be applied
whenever possible.
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Perioperative ﬂuid optimization is an established technique in
reducing morbidity after major surgery. Hypovolaemia is asso-
ciated in particular with improper organ perfusion and in-
creased length of hospital stay, while excessive ﬂuid
administration produces the clinical picture of pulmonary,
peripheral, and gut edema with associated morbidity and mor-
tality [1,2]. Intraoperative determination of ﬂuid requirement
traditionally incorporates clinical evaluation, measurement of
heart rate, arterial pressure, and central venous pressure
(CVP) which are insensitive to detect hypovolaemia [3]. Fluid
requirements necessarily vary according to individual physiol-
ogy and speciﬁc circumstances of surgery. Therefore, ﬁxed or
formula based ﬁlling regimes dependent on patient weight or
length of operation are considered to be inappropriate, and
may be unable to detect occult hypovolaemia. Previous litera-
tures suggested that perioperative goal-directed therapy
(GDT) based on ﬂow-related hemodynamic parameters im-
proves patient outcome [4,5], particularly in high-risk patients
[6,7]. Previous intraoperative ﬂuid management studies differs
largely according to study design and monitoring techniques
used. Most of the studies used were the pulmonary artery cath-
eter (PAC), which is highly invasive and may not be useful in
the routine perioperative setting [8–11].
Transesophageal Doppler (TED) is a minimally invasive
method with increasing popularity in perioperative ﬂuid ther-
apy [12]. Of the TED variables (Fig. 1), corrected ﬂow time
(FTc) has been used and evaluated as a preload index [13],
and the use of FTc for intraoperative volume optimization
has been reported to reduce the incidence of complications
and hospital stay after surgery [14]. On the other hand, respi-
ratory variations in the pulse oximeter plethysmographic
waveform amplitude have been shown to be useful in perioper-with FTc less than 350 msative ﬂuid management in the operating theatres [15]. Depend-
ing on this principle, Pleth variability index (PVI) is a novel
algorithm allowing for automated and continuous calculation
of the respiratory variations in the pulse oximeter waveform
amplitude, can also predict ﬂuid responsiveness noninvasively
in mechanically ventilated patients [16]. It measures the dy-
namic change in perfusion index (PI) that occurs during a com-
plete respiratory cycle. Pulse oximetry uses red and infrared
light and a constant amount of light (DC) from the pulse
oximeter is absorbed by skin, other tissues, and non-pulsatile
blood, whereas a variable amount is absorbed by the pulsating
arterial inﬂow. PVI calculation measures changes in PI over a
time interval sufﬁcient to include one or more complete respi-
ratory cycles as PVI = [(PImax  PImin)/PImax] X100 and is
displayed continuously (Fig. 2).
The aim of this study was to verify the impact of goal direc-
ted ﬂuid optimization using corrected ﬂow time (FTc) versus
Pleth variability index (PVI) in patients undergoing major
abdominal surgeries, regarding the intraoperative ﬂuid man-
agement, postoperative course and hospital stay.
2. Patient and method
After obtaining written informed consent and Institutional Re-
view Board approval, 60 cirrhotic patients Child A to B were
scheduled for open major abdominal surgery (intestinal resec-
tion, liver resection, whipple, hepato-biliary procedures) were
studied between January 2010 and March 2011. Patients under
18 years, permanent cardiac arrhythmias, ejection fraction
below 30% by ultrasound cardiac assessment and patients
undergoing emergency surgery were excluded from the study.
The study was a single-center, prospective randomized trial
carried out in the National Liver Institute which is a tertiary,
university afﬁliated hospital. Patients were randomized preop-Figure 2 PVI higher than 13%, 250 mL bolus of colloid were
given.
Goal directed ﬂuid optimization using Pleth variability index 25eratively either into a corrected ﬂow time ﬂuid guided protocol
group (n= 30) or Pleth variability index ﬂuid management
(n= 30) using a closed envelope system. Randomization was
performed by a member of the research team. In both groups
thoracic epidural catheter was inserted then standard general
anesthesia was induced with fentanyl 2 lg/kg, propofol 2 mg/
kg and rocuronium 0.9 mg/kg. After intubation of the trachea,
the lungs were ventilated to maintain normocapnia (end expi-
ratory partial pressure of carbon dioxide level 32–38 mm Hg)
using a constant fresh gas ﬂow of 1 L/min. Maintenance of
anesthesia was performed with sevoﬂurane, fentanyl and rocu-
ronium keeping entropy reading (GE healthcare – Helsinki,
Finland) between 40 to 60. Normothermia was achieved with
a forced-air warming device (Bair Hugger – Arizant – UK).
Standard monitoring for both groups included electrocardio-
gram, invasive arterial blood pressure via right radial artery
catheter, central venous pressure (7 Fr, 20 cm; Arrow Interna-
tional, Reading, PA) was placed through the right internal jug-
ular vein by ultrasound guided method (Sonosite – Nano Max
ultrasound system – USA), pulse oximetry, nasopharyngeal core
temperature, inspiratory and expiratory gas concentrations.
In both groups 500 mL of Ringer’s acetate were infused
during induction followed by a 2 mL/kg/h continuous infu-
sion. In the FTc group The transesophageal doppler probe
(Cardio QTM, Deltex Medical, Chichester, UK) was inserted
orally. The ideal probe tip location is at the level between
the ﬁfth and sixth thoracic vertebrae because at that level the
aorta is adjacent and parallel to the esophagus. This location
is achieved by superﬁcially land marking the distance to the
third sternocostal junction anteriorly and is approximately
30–40 cm in the average adult. After insertion, the TED probe
is then rotated on its axis to achieve an optimal signal prior to
taking measurements. For patients with corrected ﬂow time
(FTc) less than 350 ms which denotes hypovolaemia, were give
a bolus of Ringer’s acetate solution 250 ml over 5 minutes and
if no response i.e. FTc still below 350 ms, patient was followed
by bolus of colloid challenge in the form of 6% hydroxyethyl
starch solution (HES 130/0.4; Voluven; Fresenius Kabi, Stans,
Switzerland) 3 mL/kg over 5–10 min and the following proto-
col was followed: Stroke volume (SV) the same or increased,
but if FTc < 350 ms – repeat ﬂuid challenge, while if SV in-
creased by 10%, FTc > 350 ms – repeat ﬂuid challenge till
no increase in SV and when FTc > 400 ms – no further ﬂuids
till FTc or SV decreased by 10% [17].
In the PVI-group patients, the pulse oximeters (Masimo set
version, Masimo Co., Irvin, California, USA) is placed on pa-
tient’s right ﬁnger for monitoring of PVI. If PVI was higher
than 13% for more than 5 min, a bolus of Ringer’s acetate
solution 250 mL over 5 minutes and if no response i.e. PVI still
above 13%, it was followed by 250 mL bolus of the same col-
loid were given and the dose was repeated every 5 min if PVI
was still higher than 13% [18]. In both groups, norepinephrine
was given as needed to maintain a MAP more than 65 mm Hg
and hemoglobin value below 8 g/dL was considered to be a
trigger for transfusion of packed red blood cells. All patients
were admitted to the intensive care unit (ICU) postoperatively
and patients from both groups were managed by the same phy-
sicians (ICU and general ward) who were not involved in the
intraoperative management, data collection or group alloca-
tion of the study. Complications were assessed daily by senior
anesthesiologists during the ICU stay and senior surgeons dur-
ing the rest of the hospital stay and both were blinded to groupallocation and study design using standard predeﬁned criteria.
All data were collected by a resident blinded to the study de-
sign and group allocation. To ascertain comparable precondi-
tions between the groups with respect to preoperative co-
morbidity and type of surgery, all patients underwent POS-
SUM (physiological and operative severity score for the enu-
meration of mortality and morbidity) scoring by using an
online software calculator (http://www.vasgbi.com/riskpos-
sum.htm) [19]. Patients were considered to be ready for hospi-
tal discharge when they showed stable cardiovascular and
respiratory conditions, ability to take oral ﬂuids, sufﬁcient
pain control, mobilization (as far as possible), spontaneous
micturition, infection parameters within normal range, con-
sciousness comparable with the preoperative state and non-
irritated wound conditions. These criteria were classiﬁed by
specialist surgeons, who were not involved in the study design
or group allocation.2.1. Statistical analysis
Data was statistically analyzed using statistical package for so-
cial science (SPSS) program version 17 for windows and Epi
info program version. For all the analysis a P-value <0.05
was considered statistically signiﬁcant. Data were shown as
mean, standard deviation or value and 95% conﬁdence interval
(95% CI) and frequency and percent All data were tested with
Kolmogorov–Smirnov Z test and were found normally distrib-
uted and so presented with mean ± SD. Mann–Whitney test
was done for quantitative variables which were not normally
distributed and P-value<0.05 was considered signiﬁcant. Con-
tinuous, normally distributed data were compared using paired
and unpaired Student’s t-test and a Bonferroni correction for
repeated measurements was applied. Binominal data were com-
pared using chi-squared analysis and Fisher’s exact test.3. Results
There were no signiﬁcant differences in patient characteristics
regarding the age, Child classiﬁcation, co-morbid risk factors,
physiological or operative POSSUM score, surgery type or
duration, blood loss or postoperative hematology, of the two
groups were remarkably similar overall. So, it is therefore very
unlikely that patient characteristic variables might inﬂuence
the results of the study signiﬁcantly. There was no signiﬁcant
differences between both groups regarding the physiological
POSSUM score consequently it is very unlikely that preopera-
tive factors made a signiﬁcant contribution to the difference in
outcome. Also, the operative POSSUM scores were virtually
identical indicating an even overall distribution of operative
difﬁculty (Table 1). There was no signiﬁcant differences in
the volume of crystalloids or colloids transfused to both
groups (Table 2) with a mean value of 2670 ± 1680 mL and
670 ± 330 mL in the FTc guided ﬂuid group while mean val-
ues were 2730 ± 1760 mL and 690 ± 290 mL in the PVI ﬂuid
guided group respectively (P> 0.05). Postoperatively on ICU
admission and on 24 h after, there were no signiﬁcant differ-
ences between groups regarding the hemodynamic parameters
and serum lactate (Table 3). There was no signiﬁcant
difference regarding the overall morbidity or the hospital stay
(Fig. 3), between the two groups (P> 0.05) (Table 4).
Table 2 Operative data, hemodynamics and volume of
replacement.
FTc group
(n= 30)
PVI group
(n= 30)
Surgical procedure
Whipple 9 [30] 8 [26]
Liver resection 12 [40] 15 [50]
Hepato-biliary 6 [20] 5 [16]
Splenectomy 3 [10] 2 [6]
Approximate blood losses (mL) 740 (530) 810 (660)
Duration of surgery (min) 309 (103) 288 (89)
Physiologic parameters
Heart rate (beat/min)# 79 (19.6) 78 (17.8)
MAP (mm Hg)# 87 (12.2) 91 (14.9)
CVP (mm Hg)# 9.4 (3.9) 9.2 (4.1)
SpO2
# [99.1] [99.1]
Lactic acid highest value (mg/dL) 12.6 (2.9) 13.7 (2.8)
Intraoperative oligurea 4 [13] 5 [16]
Intraoperative ﬂuid
Crystalloid replacement (mL) 2670 (1680) 2730 (1760)
Colloid replacement (mL) 670 (330) 690 (290)
Blood products
PRBC (mL) 680 (430) 710 (380)
FFP (mL) 740 (270) 690 (240)
Patients receiving norepinephrine 5 [16] 5 [16]
FTc: corrected ﬂow time; PVI: Pleth variability index; bpm: beats
per minute; CVP: central venous pressure; FFP: fresh frozen
plasma; MAP: mean arterial pressure; PRBC: packed red blood
cells; oligurea denotes urine output less than 0.5 for more than two
successive hours. #Mean of values taken automatically every 5 min.
All data presented as mean (standard deviation) or [percentage].
Normal range of lactic acid (4.5–19.8 mg/dL), P> 0.05 in all data.
Table 1 Demographic data and preoperative criteria in both
groups: FTc and PVI groups.
Parameter FTc group
(n= 30)
PVI group
(n= 30)
Age (years) 56.8 (7.9) 55.6 (6.6)
Weight (kg) 80.8 (6.1) 79.1 (5.3)
Height (cm) 169 (7.6) 168 (7.9)
Gender (male/female) 10/5 9/6
Child (A/B) 17/13 16/14
Co morbid risk factors
COPD 6 (20) 5 (16)
Ischemic heart diseases 6 (20) 5 (16)
Hypertension 11 (36) 10 (33)
Renal insuﬃciency 3 (10) 3 (10)
Diabetes mellitus 13 (43) 14 (46)
Physiological POSSUM score 18 (7) 17.5 (6.5)
Operative POSSUM scores 16 (8) 15.5 (7.5)
FTc: corrected ﬂow time; PVI: Pleth variability index, COPD:
Chronic Obstructive Pulmonary Disease; POSSUM: physiological
and operative severity score. Data presented by mean (SD) or
number (%). P> 0.05 in all data.
Table 3 Postoperative hemodynamic, physiologic status and
volume of replacement in the ﬁrst 24 of ICU admission.
Parameter FTc group
(n= 30)
PVI group
(n= 30)
On admission to ICU
Mean arterial pressure (mm Hg) 84 (12.6) 83 (13.8)
Heart rate (beat/min) 82 (10.1) 81 (12.2)
CVP (mm Hg) 10 (2.4) 10.2 (1.9)
SpO2 (%) [98.3] [98.3]
Hematocrit (%) 27.1 (3.4) 27.8 (2.9)
Lactic acid highest value (mg/dL) 9.9 (2.6) 10.5 (3.1)
At 24 h after admission to ICU
Mean arterial pressure (mm Hg) 82 (9.5) 83 (8.1)
Heart rate (/min) 78 (10.8) 79 (11.2)
CVP (mm Hg) 9.4 (2.9) 9.1 (2.7)
Lactic acid highest value (mg/dL) 9.1 (2.9) 9.4 (2.6)
Postoperative oligurea 2 [6] 2 [6]
Postoperative norepinephrine IVI 2 [6] 2 [6]
ICU: intensive care unit; SpO2: oxygen saturation; CVP: central
venous pressure; oligurea denotes urine output less than 0.5 for
more than two successive hours; all data presented as mean (stan-
dard deviation) or [percentage]. Normal range of lactic acid (4.5–
19.8 mg/dL), P> 0.05 in all data.
Figure 3 Days of postoperative hospital stay of both groups.
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Fluid management and optimization in cirrhotic patients are
always the daily practice in the national liver institute eitherduring anesthesia, surgical interventions or in the postopera-
tive critical care setting. Hemodynamic management is re-
lated to the optimization of oxygen delivery to tissues and
has been shown to be able to improve postoperative outcome
and to decrease the cost of surgery [20,21]. In the operating
room, Conventional intraoperative monitoring may not pre-
dict accurately ﬂuid requirements [22]. So, the anesthesiolo-
gist and his/her patients have to deal with two risks:
hypovolemia on one side and hypervolemia on the other side.
Both risks potentially can lead to a decrease in oxygen deliv-
ery to the tissues and to an increase in postoperative morbid-
ity. On the other hand, CVP is no longer seen to be a
satisfactory measure to optimize ﬂuid administration, its use
can now be questioned intraoperatively, and there is a reduc-
tion in the use of centrally placed venous catheters in high-
risk patients undergoing major peripheral vascular and
abdominal surgery [23]. However, recent randomized trials
and meta-analyses have conﬁrmed that intraoperative ﬂuid
Table 4 Postoperative complications till discharge from the hospital.
Complication FTc group
(n= 30)
PVI group
(n= 30)
Abdominal complication
Nausea and vomiting, hematemesis, bowel obstruction, Intestinal leak, biliary leak, biliary stricture 5 [16] 4 [13]
Cardiovascular
Myocardial infarction, pulmonary edema, arrhythmia, hypotension 3 [10] 4 [13]
Hepatic decompensation
Encephalopathy, hypoalbuminemia, hyper bilirubinemia, metabolic acidosis, Progressive ascites (drains),
coagulopathy (platelet count <100,000/lm or prothrombin <50%c)\
4 [13] 5 [13]
Infection
Sepsis, pneumonia, urinary tract, wound 3 [10] 3[10]
Respiratory
Pulmonary embolism, ALI/ARDS, postoperative mechanical ventilation 3 [10] 4 [13]
Renal
Postoperative renal impairment (UOP< 500 mL/day or serum creatinine >1.7 mg/dL or dialysis)# 5 [16] 4 [13]
Postoperative mortality 0 0
Number of patients with complications 14 [46] 13 [43]
Total number of complications 23 24
Complication/patient ratio 1.64 1.84
ICU days 3.96 (0.76) 3.86 (0.72)
Hospital days 9.2 (1.71) 9.6 (2.12)
ICU: intensive care unit; ALI: acute lung injury; ARDS: adult respiratory distress syndrome. \(If platelet at least 150,000/lL preoperatively; if
prothrombin at least 70% preoperatively; #if creatinine 1.5 mg/dL or less preoperatively), UOP: urine output. All data presented as mean
(standard deviation) or [percentage]. P> 0.05 in all data.
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come, but none of the previous literatures compared between
these two tools in cirrhotic patients.
This study showed there were no signiﬁcant differences be-
tween both method used for intraoperative ﬂuid management
regarding the intraoperative ﬂuid management, postoperative
course and hospital stay.
Clinical studies have mostly shown outcome beneﬁts only
within postoperative nausea and vomiting, ileus, morbidity,
and hospital stay [27–30]. However, only limited pathophysio-
logical data are available to explain this beneﬁt. Lopes et al.
[31], in their work revealed that there is reduced morbidity
and hospital stay by GDT and this was associated with a re-
duced interleukin-6 response. Other studies on perioperative
changes of the vascular barrier suggest that the endothelial gly-
cocalyx plays a key role [28,32].
The basic advantage of the FTc derived from TED is that it
is considered as a minimally invasive tool (although there is
still the theoretical risk of esophageal trauma). The disadvan-
tages include difﬁculty in positioning the probe tip, especially
in the elderly patient. FTc is affected not only by left ventric-
ular preload but also by other haemodynamic factors, and it is
inversely proportional to the after load [33]. Moreover, hypo-
tensive patients with a low FTc may not respond to a ﬂuid
challenge in a pathological condition, which prevents adequate
ﬁlling of the left ventricle (e.g. pericardial tamponade, massive
pulmonary embolus, and tight mitral stenosis) [34]. Conse-
quently, we should put in mind that, low FTc does not always
correspond to low left ventricular preload; low FTc can even
represent a volume overload state. This means that simple ﬂuid
challenge guided by only FTc could further aggravate deterio-
ration in haemodynamic conditions [35]. However, the TED is
offering a lot of other data that help in management such sce-
narios like: cardiac output, peak velocity, systemic vascular
resistance and stroke volume.The recent availability of plethysmographic variability in-
dex (PVI) as a continuous monitor that able to analyze the
beat-to-beat changes was proved to be very useful in assessing
ﬂuid status [36]. Trending of PVI has the ability for monitoring
the surgical patients, both intraoperatively and also, postoper-
atively, for the appropriate hydration states which is consid-
ered as a privilege not present in TED, since it may show
some tolerance difﬁculties in fully awake postoperative
patients.
In conclusion, FTc and PVI are considered to be adequate
methods for perioperative ﬂuid optimization, However, there
may be no single parameter that can guide ﬂuid therapy under
all situations. Therefore, combination of every clinical ﬁnding,
recent monitoring techniques and all haemodynamic data
should be applied whenever required, even conventional
methods like CVP or PAC which if used in conjunction with
other ﬂuid monitoring tools as corrected ﬂow time (FTc), Pleth
variability index variation (PVI), Stroke volume variation
(SVV) and pulse pressure variation (PPV) and other methods
might be of a greater value in different clinical and surgical
scenarios.
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